drugset / Trial / NCT06673641
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
RandomizedParallel-groupTriple-blindTreatment
Summary
To demonstrate the efficacy, therapeutic equivalence and safety of Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel in the treatment of acne vulgaris.
Timeline
- Start
- 2024-05-13
- Primary completion
- 2024-09-03
- Completion
- 2024-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adapalene | Other / unclassified | 3.1 % | Topical |
| Subject | Benzoyl Peroxide | Other / unclassified | 1.2 % | Topical |
| Subject | Clindamycin | Unknown | 0.15 % | Topical |